Clinical Trial Update: CAR T Cells in Treating Patients With Malignant Gliomas Overexpressing EGFR [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial is evaluating CAR T cells targeting EGFR in patients with malignant gliomas, including advanced glioma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma
• Malignant Glioma

Drugs mentioned

• CAR T cell therapy targeting EGFR

Snippet

Sponsor: RenJi Hospital | Conditions: Advanced Glioma | Phase 1 | Status: UNKNOWN